COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
The primary objectives of this study are:
- To determine the proportion of children with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) related death, rehospitalization or major complications after infection with SARS-CoV-2 and/or Multisystem Inflammatory Syndrome in Children (MIS-C), and
- To determine immunologic mechanisms and immune signatures associated with disease spectrum and subsequent clinical course during the year of follow-up.
Stanford is currently accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- other: SARS-CoV-2 and/or MIS-C Exposure
Eligibility
Inclusion Criteria:
1. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) detection from a
respiratory specimen, and/or
2. Meets criteria for Multisystem Inflammatory Syndrome in Children (MIS-C), and/or
3. Meets criteria for MIS-C, except has involvement of only 1 organ system
Cases meeting clinical criteria for MIS-C but without known SARS-CoV-2 exposure, and who
are being treated as MIS-C by the treating physician, but with negative SARS-CoV-2 PCR and
pending or negative antibody testing, may be enrolled as subjects. If subsequent antibody
testing is positive, cases will be labelled as confirmed MIS-C. If SARS-CoV-2 antibody
testing is negative, subjects will be labeled at the end of the study as suspected/not
confirmed MIS-C.
Exclusion Criteria:
1. Subject and/or parent/guardian who are not able to understand or be willing to provide
informed consent and where applicable assent
--Note, for this observational cohort study, participation in other COVID-19 studies is not
an automatic exclusionary criterion.
Ages Eligible for Study
N/A - 20 Years
Genders Eligible for Study
All
Now accepting new patients
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Olivia Martinez
650-498-6247
I'm interested
Our research team includes physicians, residents, medical students, research assistants, and volunteers. Our research topics include medical imaging, device validation, mobile application development, and pharmaceutical trials.
Some of the Neuro-Opthalmic concerns we investigate include Multiple Sclerosis, Optic Neuritis, IIH, and ICP.
